Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015, as amended from time to time, read with para A of Schedule III thereto, Concord Biotech has informed that the company has arranged Earning Call with Investor/Analyst (Participants) to discuss the standalone and consolidated Financial Results of the Company for the quarter and year ended 31 March 2024 scheduled on Tuesday 28th May, 2024 at 4:00 PM IST. The Earning Call invite is enclosed.
The above information is a part of company’s filings submitted to BSE.
